Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema

Status:
Terminated

Trial end date:
2011-02-01

Target enrollment:

Participant gender:

To assess the efficacy of oral aliskiren as a therapy for diabetic macular edema

Phase 2

Novartis Pharmaceuticals